- ICH GCP
- Registro de ensaios clínicos dos EUA
- Ensaio Clínico NCT04982042
Post COVID-19 Pulmonary Rehabilitation Program (COVID19REHAB)
Outpatient and Home Pulmonary Rehabilitation Program for Post COVID-19 Patients
Coronavirus-2019 disease (COVID-19) is a highly infectious respiratory disease that causes respiratory, physical and psychological dysfunction in patients.
With the increased understanding of the severity of COVID-19 and clinical evidence in accordance with the opinions of first-line clinical experts involved in the treatment of this epidemic, the investigators believe that the participation of patients with sequelae of COVID-19 in a Pulmonary Rehabilitation Program would be of utmost importance.
According to recent scientific recommendations for patients with sequelae of COVID-19, respiratory rehabilitation would alleviate symptoms of dyspnea, anxiety and depression and, eventually, improve physical functions and quality of life.
Therefore, it is essential to anticipate early rehabilitation after the acute phase of ARDS, in order to limit the severity of the effects of the ICU and promote rapid functional recovery. Physiotherapy will play a role in providing exercise, mobilization and rehabilitation interventions for survivors of critical illnesses associated with COVID-19, in order to enable a functional social return.
Visão geral do estudo
Status
Condições
Intervenção / Tratamento
Descrição detalhada
The investigatores propose a clinical, prospective and consecutive study composed of participants with pulmonary sequelae of COVID-19 and pulmonary diseases such as COPD, Asthma, Bronchitis, Emphysema, Bronchiectasis and pulmonary fibrosis. Initially, all patients will undergo a physical assessment, pulmonary function tests and nutritional assessment, in addition to applying the modified dyspnea scale of the MMRC (Modified Medical Research Council) and the 6-minute walk test (6MWT), according to the standards recommended by the American Thoracic Society (ATS).
The proposed Outpatient and Home Pulmonary Rehabilitation Program is based on the Guidelines recommended by the Brazilian Society of Pulmonology (SBPT) and by the Global Initiative for Chronic Obstructive Lung Disease (GOLD), with a minimum duration of 12 weeks, frequency of 3 weekly sessions, accompanied by health professionals in this field.
Patients who seek care at municipal and state health services in the city of Anápolis, (Goiás) will be recruited. Patients with clinically stabilized COVID - 19 sequelae will be considered eligible, and who agree to participate in the study, signing the Informed Consent .
The outpatient PRP consisted of a combination of aerobic and strengthening exercises, lasting 12 weeks, frequency 3 times a week. Each session will consist of active warm-up exercises, upper and lower limb strengthening, aerobic conditioning and stretching exercises. The warm-up phase consists of intercalated calisthenic exercises for different muscle groups, according to each patient's tolerance.
Tipo de estudo
Inscrição (Antecipado)
Estágio
- Não aplicável
Contactos e Locais
Contato de estudo
- Nome: Luis LV Oliveira, PhD
- Número de telefone: 0055 62 999052309
- E-mail: oliveira.lvf@gmail.com
Estude backup de contato
- Nome: Luis VF Oliveira, PhD
- Número de telefone: 0055 62 999052309
- E-mail: luis.oliveira@unievangelica.edu.br
Locais de estudo
-
-
GO
-
Anápolis, GO, Brasil, 75083-515
- Recrutamento
- Centro Universitário de Anápolis - UniEVANGÉLICA
-
Contato:
- Luis VF Oliveira, PhD
- Número de telefone: 6717 +55 62 33106600
- E-mail: oliveira.lvf@gmail.com
-
-
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
Aceita Voluntários Saudáveis
Gêneros Elegíveis para o Estudo
Descrição
Inclusion Criteria:
- Patients with a diagnosis of pulmonary sequelae post COVID-19
- Patients clinically stabilized
- Who agreed to participate in the clinical study, signing the informed consent form, will be considered eligible.
Exclusion Criteria:
- Hospitalized patients
- Patients who present clinical instability
- Patients who do not commit to adhering to the Pulmonary Rehabilitation Program
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Tratamento
- Alocação: Não randomizado
- Modelo Intervencional: Atribuição Paralela
- Mascaramento: Solteiro
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
|---|---|
|
Experimental: Post COVID-19 Outpatient Pulmonary Rehabilitation Program
The outpatient Pulmonary Rehabilitation Program will be carried out at the Pulmonary Rehabilitation Laboratory, consisting of a combination of aerobic and strengthening exercises, lasting 12 weeks, with a frequency of 3 times a week, always in the morning.
Each session consists of active warm-up exercises, upper and lower limb strengthening, aerobic conditioning and stretching exercises.
The warm-up phase consists of intercalated calisthenic exercises for different muscle groups, according to each patient's tolerance.
|
The Pulmonary Rehabilitation Program consists of a combination of aerobic and strengthening exercises, lasting 12 weeks, with a frequency of 3 times a week, always in the morning.
Each session consists of active warm-up exercises, upper and lower limb strengthening, aerobic conditioning and stretching exercises.
The warm-up phase consists of intercalated calisthenic exercises for different muscle groups, according to each patient's tolerance.
|
|
Comparador Ativo: Post COVID-19 Home Pulmonary Rehabilitation Program
The Home Pulmonary Rehabilitation Program will be carried out at the patients' homes, consisting of the same combination of aerobic and strengthening exercises, lasting 12 weeks, 3 times a week, always in the morning.
Each session consists of active warm-up exercises, upper and lower limb strengthening, aerobic conditioning and stretching exercises.
The warm-up phase consists of intercalated calisthenic exercises for different muscle groups, according to each patient's tolerance.
Patients will be monitored weekly via whatsapp.
|
The Pulmonary Rehabilitation Program consists of a combination of aerobic and strengthening exercises, lasting 12 weeks, with a frequency of 3 times a week, always in the morning.
Each session consists of active warm-up exercises, upper and lower limb strengthening, aerobic conditioning and stretching exercises.
The warm-up phase consists of intercalated calisthenic exercises for different muscle groups, according to each patient's tolerance.
|
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Functional status after Pulmonary Rehabilitation Program (COVID-19REHAB)
Prazo: 12 weeks
|
Effects of an Ambulatory and Home Pulmonary Rehabilitation Program on levels of functional status assessed with the Medical Research Council (MRC) Scale in patients with pulmonary sequelae resulting from COVID-19.
|
12 weeks
|
|
Exercise capacity after Pulmonary Rehabilitation Program (COVID-19REHAB)
Prazo: 12 weeks
|
Effects of an Ambulatory and Home Pulmonary Rehabilitation Program on exercise capacity assessed with the six minutes Walk Test ( 6MWT) in patients with pulmonary sequelae resulting from COVID-19.
|
12 weeks
|
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Forced Vital Capacity after Pulmonary Rehabilitation Program (COVID-19REHAB)
Prazo: 12 weeks
|
Effects of an Ambulatory and Home Pulmonary Rehabilitation Program on the forced vital capacity (FVC) measured by spirometry in patients with pulmonary sequelae resulting from COVID-19.
|
12 weeks
|
|
Forced Expiratory Volume in first second after Pulmonary Rehabilitation Program (COVID-19REHAB)
Prazo: 12 weeks
|
Effects of an Ambulatory and Home Pulmonary Rehabilitation Program on the forced expiratory volume in first second (FEV1) measured by spirometry in patients with pulmonary sequelae resulting from COVID-19.
|
12 weeks
|
|
Inspiratory muscle strength after Pulmonary Rehabilitation Program (COVID-19REHAB)
Prazo: 12 weeks
|
Effects of an Ambulatory and Home Pulmonary Rehabilitation Program on the inspiratory muscles strength measured by vacuometry in patients with pulmonary sequelae resulting from COVID-19.
|
12 weeks
|
|
Peripheral muscle strength after Pulmonary Rehabilitation Program (COVID-19REHAB)
Prazo: 12 weeks
|
Effects of an Ambulatory and Home Pulmonary Rehabilitation Program on the peripheral muscle strength measured by Hand Grip Dynamometer in patients with pulmonary sequelae resulting from COVID-19.
|
12 weeks
|
|
Levels of anxiety and depression after Pulmonary Rehabilitation Program (COVID-19REHAB)
Prazo: 12 weeks
|
Effects of an Ambulatory and Home Pulmonary Rehabilitation Program on the Anxiety and depression levels measured by the Hospital Anxiety and Depression scale in patients with pulmonary sequelae resulting from COVID-19.
|
12 weeks
|
|
Quality of Life after Pulmonary Rehabilitation Program (COVID-19REHAB)
Prazo: 12 weeks
|
Effects of an Ambulatory and Home Pulmonary Rehabilitation Program on the Quality of Life levels measured by Medical Outcomes Study/SF-36 Questionnaire in patients with pulmonary sequelae resulting from COVID-19.
|
12 weeks
|
|
Health costs after COVID - 19.
Prazo: 36 weeks
|
Effects of an Ambulatory and Home Pulmonary Rehabilitation Program on healthcare costs verified through the financial expenses of patients with pulmonary sequelae resulting from COVID-19.
|
36 weeks
|
Colaboradores e Investigadores
Patrocinador
Investigadores
- Investigador principal: Luis VF OLiveira, PhD, Evangelical University of Goiás - UNIEVANGELICA
Publicações e links úteis
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo (Real)
Conclusão Primária (Antecipado)
Conclusão do estudo (Antecipado)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Real)
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Palavras-chave
Termos MeSH relevantes adicionais
- Transtornos Mentais, Desordem Mental
- Processos Patológicos
- Doenças do Sistema Nervoso
- Infecções por coronavírus
- Infecções por Coronaviridae
- Infecções por Nidovírus
- Infecções por vírus de RNA
- Doenças Virais
- Infecções
- Doenças Respiratórias
- Distúrbios Respiratórios
- Pneumonia Viral
- Pneumonia
- Manifestações Neurológicas
- Doenças musculoesqueléticas
- Doenças Musculares
- Manifestações Neuromusculares
- COVID-19
- Doenças pulmonares
- Fraqueza muscular
- Insuficiência Respiratória
- Transtornos de ansiedade
- Infecções do Trato Respiratório
Outros números de identificação do estudo
- COVID-19 PULMONARY REHAB
Plano para dados de participantes individuais (IPD)
Planeja compartilhar dados de participantes individuais (IPD)?
Descrição do plano IPD
Prazo de Compartilhamento de IPD
Critérios de acesso de compartilhamento IPD
Tipo de informação de suporte de compartilhamento de IPD
- PROTOCOLO DE ESTUDO
- SEIVA
- CIF
- CSR
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .